😴 Uh Oh, Asleep!
- Malignant Hyperthermia (MH):
- Triggers: Succinylcholine, volatile anesthetics.
- Patho: Defective ryanodine receptor (RYR1) → massive intracellular Ca²⁺ release.
- Sx: Fever, muscle rigidity, tachycardia, ↑ETCO₂, rhabdomyolysis.
- Laryngospasm: Vocal cord adduction → obstruction. Tx: Positive pressure ventilation, deepen anesthesia, succinylcholine.
- Aspiration Pneumonitis: Prevent with NPO status & rapid sequence intubation.
- Hypotension: Common with propofol, volatiles, neuraxial block.
⭐ Dantrolene treats MH by binding the RYR1 receptor, blocking Ca²⁺ release from the sarcoplasmic reticulum.
🎭 Pathophysiology - The Dantrolene Drama
-
Malignant Hyperthermia (MH): Autosomal dominant defect in ryanodine receptor (RYR1). Triggers like volatile anesthetics or succinylcholine cause massive, uncontrolled $Ca^{2+}$ release from the sarcoplasmic reticulum.
- Leads to: Hypermetabolism (↑temp, ↑ETCO₂), muscle rigidity, rhabdomyolysis (↑K⁺, ↑CK), and acidosis.
- Tx: Dantrolene, a RYR1 antagonist.
-
Anaphylaxis: Type I (IgE-mediated) hypersensitivity. Triggers (e.g., neuromuscular blockers, antibiotics) cause mast cell degranulation, releasing histamine.
- Leads to: Vasodilation (hypotension), bronchospasm, urticaria.
- Tx: Epinephrine.
⭐ The earliest, most sensitive sign of MH is an unexpected rise in end-tidal $CO_2$ (ETCO₂).
🚩 Clinical Manifestations - Red Flags Rising
| Complication | Key Signs & Symptoms |
|---|---|
| Malignant Hyperthermia (MH) | Sudden ↑ETCO₂ (earliest), tachycardia, masseter muscle rigidity, hyperkalemia, hyperthermia (late). |
| Local Anesthetic Systemic Toxicity (LAST) | 📌 Biphasic: CNS excitation (perioral numbness, tinnitus, seizures) followed by CNS depression (coma, respiratory arrest) & CV collapse. |
| Anaphylaxis | Sudden severe hypotension, bronchospasm (↑peak airway pressure), tachycardia, urticaria, angioedema. |
| Perioperative MI | Often silent ("painless"). May manifest as unexplained hypotension, new arrhythmia (e.g., AFib), or ST changes on ECG. |
🩺 Diagnosis - Spotting the Trouble
- Monitor Vitals & Capnography: The first line of detection.
- Malignant Hyperthermia (MH): Unexplained ↑ ETCO2 is the earliest sign. Followed by tachycardia, muscle rigidity, and hyperthermia (late).
- Anaphylaxis: Sudden ↓ BP, ↑ HR, bronchospasm, rash. Confirm with ↑ serum mast cell tryptase.
- MH Susceptibility: Caffeine-halothane contracture test (gold standard); genetic testing for RYR1 mutations for at-risk families.
⭐ An abrupt, unexplained rise in end-tidal CO₂ is the most sensitive sign of Malignant Hyperthermia, often preceding fever.
🚨 Management - Code Blue Anesthesia
- Malignant Hyperthermia (MH): Immediate, stepwise intervention is critical.
-
Local Anesthetic Systemic Toxicity (LAST):
- Manage ABCs; treat seizures with benzodiazepines.
- Administer 20% lipid emulsion therapy.
-
Anaphylaxis:
- Epinephrine is first-line (0.3-0.5 mg IM).
- Secure airway, IV fluids, H1/H2 blockers, corticosteroids.
⭐ Dantrolene acts by blocking ryanodine receptors (RyR1) in skeletal muscle, preventing Ca²⁺ release from the sarcoplasmic reticulum, directly treating MH pathophysiology.
⚡ High-Yield Points - Biggest Takeaways
- Malignant Hyperthermia (MH): Triggered by succinylcholine/volatile anesthetics. Presents with fever, rigidity, and ↑CK. Treat with dantrolene.
- Local Anesthetic Systemic Toxicity (LAST): CNS changes (seizures) and cardiovascular collapse. The antidote is intralipid emulsion.
- Postoperative Fever: Early fever (<48h) is often non-infectious (atelectasis). Later fever suggests infection (UTI, wound).
- Aspiration Pneumonitis: Chemical lung injury. Prevent with NPO status and rapid sequence intubation.
- Succinylcholine can cause life-threatening hyperkalemia in burn, crush, or neuromuscular disease patients.
- Postoperative hypothermia impairs coagulation and increases wound infection risk.
Continue reading on Oncourse
Sign up for free to access the full lesson, plus unlimited questions, flashcards, AI-powered notes, and more.
CONTINUE READING — FREEor get the app